lamivudine has been researched along with Lymphoma, Follicular in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gil, E; Hewitt, P; Manson, J; Parker, S; Reyal, Y; Ward, K; Wilson, S | 1 |
| Arcaini, L; Bruno, R; Lucioni, M; Merli, M; Paulli, M; Rattotti, S; Riboni, R; Vercelli, A | 1 |
| Castellví, JM; del Río, N; Diloy, R; Hernández, JA; Martínez, X; Salat, D | 1 |
| Ali, JA; Harrigan, PR; Law, JK; Savage, KJ; Sherlock, CH; Yoshida, EM | 1 |
| Ahmed, A; Keeffe, EB | 1 |
5 other study(ies) available for lamivudine and Lymphoma, Follicular
| Article | Year |
|---|---|
Case report: passive transfer of hepatitis B antibodies from intravenous immunoglobulin.
Topics: Antiviral Agents; Hematopoietic Stem Cell Transplantation; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Core Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Lamivudine; Lymphoma, Follicular; Male; Medical Errors; Middle Aged; Serologic Tests | 2014 |
Regression of indolent B-cell lymphoma after Lamivudine prophylaxis of hepatitis B virus infection.
Topics: Antiviral Agents; Asymptomatic Diseases; Bone Marrow; Carrier State; Cell Transformation, Viral; Disease Progression; Female; Genes, bcl-2; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Lymphoma, B-Cell; Lymphoma, Follicular; Middle Aged; Neoplasm, Residual; Remission Induction; Splenic Neoplasms | 2011 |
Fulminant hepatitis subsequent to reactivation of precore mutant hepatitis B virus in a patient with lymphoma treated with chemotherapy and rituximab.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antiviral Agents; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Lymphoma, Follicular; Mutation; Rituximab | 2003 |
Fatal postlymphoma chemotherapy hepatitis B reactivation secondary to the emergence of a YMDD mutant strain with lamivudine resistance in a noncirrhotic patient.
Topics: Antineoplastic Combined Chemotherapy Protocols; Drug Resistance, Viral; Fatal Outcome; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Lymphoma, Follicular; Male; Middle Aged; Mutation; Reverse Transcriptase Inhibitors; Virus Activation | 2006 |
Lamivudine therapy for chemotherapy-induced reactivation of hepatitis B virus infection.
Topics: Acute Disease; Antineoplastic Agents; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Lymphoma, Follicular; Male; Middle Aged; Reverse Transcriptase Inhibitors; Virus Activation | 1999 |